Business Wire (Wed, 4:10PM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
1,342 people get NPSP articles and Market Currents by email alert.
Get email alerts on NPSP »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (Tue, 5:57PM)
-
Business Wire (Mon, 4:21PM)
-
Business Wire (May 9, 2013)
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 26, 2013)
-
Business Wire (Apr 22, 2013)
-
-
-
-
-
-
-
Business Wire (Mar 5, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
-
-
Current Prime Pharma Entries In Anticipation Of Prime Time ExitsChemistfrog • Tue, Nov 6, 2012 -
-
What Moves Biotech Stocks? Ed Arce Has AnswersLife Sciences Report • Thu, Oct 18, 2012 -
-
-
-
-
-
NPS Pharmaceuticals' CEO Discusses Gattex Update (Transcript)Wed, Oct 17, 2012 • 1 Comment
-
NPS Pharmaceuticals, Inc. Q1 2010 Earnings Call TranscriptThu, May 6, 2010
-
NPS Pharmaceuticals Inc. Q4 2008 Earnings Call TranscriptFri, Mar 13, 2009
-
NPS Pharmaceuticals, Inc. Q2 2008 Earnings Call TranscriptTue, Sep 2, 2008
-
Business Wire (Wed, 4:10PM)
-
Business Wire (Tue, 5:57PM)
-
Business Wire (Mon, 4:21PM)
-
Business Wire (May 9, 2013)
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 26, 2013)
-
Business Wire (Apr 22, 2013)
-
Business Wire (Mar 5, 2013)
-
Business Wire (Feb 21, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Feb 13, 2013)
-
Business Wire (Feb 5, 2013)
-
at CNBC.com (Jan 7, 2013)
-
Business Wire (Jan 3, 2013)
NPSP vs. ETF Alternatives
Company Description
Currently, there's no company description for NPSP.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, March 19, 8:18 AM NPS Pharmaceuticals (NPSP) has bought back the none-North American rights to two drugs from Takeda for $50M in shares and possible milestone payments, giving NPS with full global rights to the treatments. The drugs are Revestive (Gattex in the U.S.), a medicine for short bowel syndrome, and Preotact, a thyroid hormone replacement therapy. (PR) Comment! [Healthcare, M&A]
-
Codespeed
$NBIX $NPSP technical charts, strong catalysts, good returns: http://seekingalpha.com/a/syx1 - View all 0 replies
-
- View all 1 replies
-
-
- View all 1 replies
-
whitehead1: I missed and missed and missed. Please go under 5 for one more time please
-
smokeyRose
Should i sell Should i sell My $JAZZ and $NPSP and Buy $SRPT ????? What to do What To Do What To Do - View all 2 replies
-
-
-
- View all 0 replies
-
Corey Papcun
NPSP was scheduled to report 3rd quarter earnings today at 4:30. Are they holding off due to the election? - View all 1 replies
-
-
freefdawatchlist
http://stks.co/mCem Premarket loser $FTNT (-16%), $APOL (-12%), $ISRG (-5%), $NPSP (-4%), $INTC(-4%) - View all 0 replies
-
- View all 0 replies
-
Michael Bryant
"FDA staff says NPS Pharma's (NPSP) bowel drug needs no safety restrictions." Drug may be nearing approval. http://bit.ly/SWHPDY - View all 0 replies
-
- View all 1 replies
-
LATEST REPLIES
-
- View all 1 replies
-
-
- View all 1 replies
-
whitehead1: I missed and missed and missed. Please go under 5 for one more time please
-
smokeyRose
Should i sell Should i sell My $JAZZ and $NPSP and Buy $SRPT ????? What to do What To Do What To Do - View all 2 replies
-
-
-
Corey Papcun
NPSP was scheduled to report 3rd quarter earnings today at 4:30. Are they holding off due to the election? - View all 1 replies
-
-
- View all 1 replies
-